First Tracks Biotherapeutics, Inc.: updates and filings

TRAXNASDAQHealthcare · Pharmaceutical PreparationsNew listingsince Apr 1, 2026

Price

$41.64

November 20, 2026Market cap $1.7B

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Nov 3, 2026 latest quarterly
  • Nov 12, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 3, 2026Results of operations
    Form8-K
  • Oct 29, 2026Filing
    FormEFFECT
  • Oct 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 26, 2026Filing
    FormS-1
  • Oct 20, 2026Material agreement entered
    Form8-K
  • Oct 15, 2026Material agreement entered, unregistered sale of shares, Regulation FD disclosure
    Form8-K
  • Oct 13, 2026Regulation FD disclosure, other material events
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 14, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 13, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 12, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 12, 2026Results of operations
    Form8-K
  • Aug 6, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jul 28, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jun 22, 2026Material agreement entered
    Form8-K
  • May 14, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 14, 2026Results of operations
    Form8-K
  • May 12, 2026Filing
    FormEFFECT
  • May 8, 2026Correspondence with the SEC
    FormCORRESP
  • May 8, 2026Filing
    FormS-1
  • May 6, 2026Letter from the SEC
    FormUPLOAD
  • May 1, 2026Filing
    FormDRS

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 6, 2026.

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.